CardioExchange Archive

July 16th, 2012

Ticagrelor Joins Clopidogrel and Prasugrel in Updated NSTEMI Guidelines

Larry Husten, PHD

Ticagrelor (Brilinta, AstraZeneca) gains equal standing with prasugrel (Effient, Lilly) and clopdiogrel in the newly released focused update of the ACCF/AHA guidelines for unstable angina and non-ST-elevation myocardial infarction (NSTEMI). The change had been widely anticipated since last year’s FDA approval of ticagrelor. “We have put it on equal footing with two other antiplatelet medications, clopidogrel […]

---

April 10th, 2011

Questioning the Guidelines

scottwright109 and Hansie Mathelier, MD

CardioExchange welcomes R Scott Wright, the chair of the recently published focused update of the ACC/AHA Unstable Angina/NSTEMI guidelines. Dr. Wright generously agreed to answer questions about the guidelines posed by the CardioExchange editors. CardioExchange Editors: For clinicians reading this guidelines update, what would you highlight as the most important new or revised recommendations that should […]

---

March 28th, 2011

Updated Unstable Angina/Non-STEMI Guidelines Released by ACC & AHA

Larry Husten, PHD

The AHA and ACC have released a focused update of the 2007 guidelines for the management of unstable angina and non-STEMI. The guidelines incorporate new information from recent clinical trials, and deal with controversial topics such as the choice of antiplatelet agents, the use of platelet-function and genetic tests with antiplatelet agents, and the timing […]

---